Henkel has launched a novel medical-grade light-cure adhesive designed for devices that are to be worn on the body. The new product is formulated without IBOA (isobornyl acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices, making it a robust option for new designs.
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 have both been tested according to ISO 10993 standards, ensuring a high level of safety and performance for users.
“At Henkel, we are committed to providing our customers with innovative adhesive solutions that meet the highest safety standards,” said Philipp Loosen, vice president and head of Industrials EIMEA and Global Key Accounts Medical at Henkel. ”With the introduction of our new medical grade wearable device light cure adhesive, we are addressing the growing need for safe and effective adhesives in the medical industry. Our adhesive is ISO 10993 tested and formulated with patient comfort and safety in mind, ensuring its suitability for use in medical device bonding and medical wearables.”
Henkel's wearable-device light-cure adhesive offers various benefits for medical applications. Its light-cure capabilities allow for quick and efficient bonding, reducing production time and increasing productivity. The adhesive also provides excellent adhesion to a wide range of substrates commonly used in medical devices and wearables, ensuring robust bonding and sealing performance after drop impact or bathing.
For more information, visit www.henkel.com.